# 2026年2月11日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 利用转基因异种猪肝对脑死亡受试者进行体外肝脏交叉循环的研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41663593)
**期刊：** Nature medicine
**PMID：** 41663593
**DOI：** 10.1038/s41591-025-04196-3

### 第一部分 原文与翻译

**英文原标题：** Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents.

> **英文摘要：**
> Extracorporeal liver cross-circulation (ELC) using genetically modified pig livers may address an unmet need for temporary liver support in patients with acute or acute-on-chronic liver failure. This study used the ELC platform to evaluate early immune responses and assess xenogeneic liver physiological support in a human decedent model. Four human decedents underwent ELC using pig livers with a triple glycan knockout; insertion of seven human transgenes and inactivation of pig endogenous retroviruses. Intravenous methylprednisolone was administered for immunosuppression. In the case of decedents 1-3, ELC was performed for 72-84 h with the native livers of the decedents remaining in situ. In the case of decedent 4, hepatectomy was performed, followed by 48 h of xenogeneic liver support exclusively using ELC. Biopsies of xenogeneic livers demonstrated preserved parenchymal architecture, mild immune infiltration and IgM deposition. Xenogeneic livers produced bile and supplemented native hepatocellular function. In decedent 4, xenogeneic liver-only support after hepatectomy maintained hemodynamic stability, normal pH, lactate, ammonia, international normalized ratio and sustained metabolic function. This study shows that ELC is feasible using xenogeneic livers with minimal immunosuppression and can provide effective liver support.

> **中文摘要：**
> 使用基因修饰猪肝的体外肝脏交叉循环（ELC）可能解决急性或慢加急性肝衰竭患者对临时肝脏支持的迫切需求。本研究利用 ELC 平台，在人类脑死亡受试者模型中评估了早期免疫反应并评估了异种肝脏的生理支持作用。四名人类受试者接受了 ELC，使用的是经过三处聚糖基因敲除、插入七个人类转基因并灭活猪内源性逆转录病毒的猪肝。静脉注射甲泼尼龙进行免疫抑制。在受试者 1-3 的案例中，ELC 进行了 72-84 小时，且受试者的原生肝脏保留在原位。在受试者 4 的案例中，研究人员在肝切除术后，仅使用 ELC 进行了 48 小时的异种肝脏支持。异种肝脏的活检显示，其保留了实质结构，伴有轻度的免疫浸润和 IgM 沉积。异种肝脏能够产生胆汁并补充了原生肝细胞功能。在受试者 4 中，肝切除术后的纯异种肝脏支持维持了血流动力学稳定、正常的 pH 值、乳酸、血氨、国际标准化比值（INR）以及持续的代谢功能。本研究表明，在极低免疫抑制条件下使用异种肝脏进行 ELC 是可行的，并能提供有效的肝脏支持。

### 第二部分 AI 大师评价

本研究利用多基因修饰（10个基因修饰点）的猪肝，在脑死亡人类模型中成功验证了体外肝脏交叉循环（ELC）的生理支持效能。研究通过对肝切除受试者的极端模型测试，证实了异种肝脏能有效代偿人类肝脏的代谢与内环境稳态维持功能，且仅需微弱的免疫抑制。该成果为急性肝衰竭患者提供了一种创新的过渡性支持方案，在异种移植临床转化领域具有里程碑意义，但在长期安全性和超急性排斥反应的监测上仍需进一步探索。

---

## 2. 小分子 SMT-738 作用于细菌脂蛋白转运体 LolCDE 的分子机制

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41663437)
**期刊：** Nature communications
**PMID：** 41663437
**DOI：** 10.1038/s41467-026-69411-2

### 第一部分 原文与翻译

**英文原标题：** Molecular mechanism of action of small molecule SMT-738 on bacterial lipoprotein transporter LolCDE.

> **英文摘要：**
> SMT-738 is a small molecule with promising antibacterial activity against Enterobacteriaceae, including multi-drug-resistant Escherichia coli. Mutations in genes encoding the lipoprotein transport complex (LolCDE) confer resistance to SMT-738. Here, we report the cryogenic electron microscopy structure of the LolCDE-SMT-738 complex at a high resolution. We use mutagenesis, drug resistance assays, biochemical assays, and molecular dynamics simulations to show that SMT-738 binds to the periplasmic end of the LolCE transmembrane domains. This binding induces an allosteric conformational change in the cytoplasmic end of the LolCE transmembrane domains and the coupling helices, leading to dissociation of one LolD subunit from the LolCDE complex. This structural disruption results in a "deadlock" of the LolCDE complex, rendering a transport-incompetent state. Our findings also provide insights into the mechanism of SMT-738 resistance and selectivity.

> **中文摘要：**
> SMT-738 是一种对肠杆菌科（包括多重耐药大肠杆菌）具有良好抗菌活性的小分子。编码脂蛋白转运复合物 (LolCDE) 的基因突变会导致对 SMT-738 的耐药性。在此，我们报道了 LolCDE-SMT-738 复合物的高分辨率冷冻电镜结构。我们通过诱变、耐药性测定、生化实验和分子动力学模拟表明，SMT-738 结合在 LolCE 跨膜结构域的周质端。这种结合诱导了 LolCE 跨膜结构域胞质端和偶联螺旋的变构构象变化，导致一个 LolD 亚基从 LolCDE 复合物中解离。这种结构破坏导致 LolCDE 复合物发生“死锁”，使其处于丧失转运能力的状态。我们的研究结果还为 SMT-738 的耐药机制和选择性提供了见解。

### 第二部分 AI 大师评价

本研究通过高分辨率冷冻电镜技术，结合生化实验与分子动力学模拟，精确揭示了抗菌小分子 SMT-738 抑制细菌 LolCDE 复合物的独特变构机制。研究发现该药物通过结合周质端诱发跨膜区构象变化，导致核心亚基解离并形成转运“死锁”，从而发挥抗菌效力。这一发现不仅为针对革兰氏阴性菌脂蛋白转运途径的药物研发提供了重要的结构基础，也为理解和克服临床耐药性提供了关键线索。

---

## 3. 妊娠仓鼠模型中与 COVID-19 相关的胎盘炎症阻碍胎儿发育

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41663418)
**期刊：** Nature communications
**PMID：** 41663418
**DOI：** 10.1038/s41467-026-69360-w

### 第一部分 原文与翻译

**英文原标题：** COVID-19-related inflammation of the placenta impedes fetal development in pregnant hamsters.

> **英文摘要：**
> Pregnant women are at higher risk of severe COVID-19, with vaccine access and hesitancy remaining a challenge. Here, we use a pregnant female hamster model of COVID-19 to explore the effects of maternal infection on pregnancy, revealing a significant increase in intrauterine growth restriction (IUGR) due to placental inflammation. Viral infection causes bronchopneumonia and weight loss in infected dams, but no vertical transmission occurs. IUGR is instead linked to placental damage, characterized by fibrin deposition, thrombosis, and elevated placental expression of IP10, IL6, and IL10, irrespective of fetal sex. Enoxaparin treatment reduces placental damage and improves fetal outcomes, while vaccination enhances viral clearance, protects the placenta, and reduces the risk of IUGR. These findings underscore placentitis as a key driver of fetal complications upon SARS-CoV-2 infection and highlight the potential of vaccination and anticoagulant therapy to protect both mother and child.

> **中文摘要：**
> 孕妇患重症 COVID-19 的风险更高，而疫苗获取和接种犹豫仍是挑战。在本研究中，我们利用妊娠雌性仓鼠 COVID-19 模型探索母体感染对妊娠的影响，揭示了由于胎盘炎症导致的宫内生长受限 (IUGR) 显著增加。病毒感染在受感染的母体中引起支气管肺炎和体重减轻，但未发生垂直传播。IUGR 反而与胎盘损伤有关，其特征是纤维蛋白沉积、血栓形成以及胎盘中 IP10、IL6 和 IL10 的表达升高，且与胎儿性别无关。依诺肝素治疗可减轻胎盘损伤并改善胎儿结局，而疫苗接种可增强病毒清除、保护胎盘并降低 IUGR 风险。这些发现强调了胎盘炎是 SARS-CoV-2 感染后胎儿并发症的关键驱动因素，并突出了疫苗接种和抗凝治疗在保护母婴方面的潜力。

### 第二部分 AI 大师评价

本研究通过妊娠仓鼠模型深入探讨了 SARS-CoV-2 感染对胎儿发育的影响，发现胎盘炎症而非病毒垂直传播是导致宫内生长受限（IUGR）的核心机制。研究通过详细的病理分析，证实了胎盘损伤中的血栓形成及炎症因子升高与胎儿发育受损直接相关。创新性地验证了依诺肝素抗凝治疗与疫苗接种在保护胎盘功能和改善胎儿结局中的显著作用，为临床管理感染 COVID-19 的孕妇提供了重要的实验依据和潜在的干预策略。

---

## 4. 新生儿重症监护病房中金黄色葡萄球菌的快速传播与侵入性感染相关

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41663361)
**期刊：** Nature communications
**PMID：** 41663361
**DOI：** 10.1038/s41467-026-69074-z

### 第一部分 原文与翻译

**英文原标题：** Rapid dissemination of Staphylococcus aureus in the neonatal intensive care unit is associated with invasive infection.

> **英文摘要：**
> Staphylococcus aureus is a leading cause of severe infections in neonatal intensive care units (NICUs). We present results of precision surveillance of S. aureus carriage and invasive infection in a cohort study of high-risk infants in the NICU with the goal of identifying novel strategies for prevention and control. Using whole genome sequence guided epidemiology over a 3-year timeframe, we identify spatial and temporal links for transmission between babies, suggesting shared spaces, caregivers, and physical proximity as major risks for transmission in the NICU. Moreover, environmental surveillance reveals potential environmental reservoirs of S. aureus. Remarkably, specific clusters of S. aureus strains that are associated with invasive infection are also detected in more infants over time during routine surveillance, suggesting a strong link between the rate of dissemination and disease in this vulnerable population. Overall, our findings demonstrate a strong association amongst colonization, transmission, persistence, and the development of invasive infections, underscoring the importance of targeted measures to prevent S. aureus infections in the NICU setting.

> **中文摘要：**
> 金黄色葡萄球菌是新生儿重症监护病房（NICU）严重感染的主要原因。我们在NICU高危婴儿队列研究中，对金黄色葡萄球菌的携带和侵入性感染进行了精准监测，旨在确定预防和控制的新策略。通过为期3年的全基因组测序引导的流行病学研究，我们确定了婴儿间传播的空间和时间联系，表明共享空间、护理人员和物理亲近是NICU内传播的主要风险。此外，环境监测揭示了金黄色葡萄球菌潜在的环境蓄积库。值得注意的是，随着时间的推移，在常规监测中，更多婴儿被检测出与侵入性感染相关的特定金黄色葡萄球菌菌株簇，这表明传播速度与这一脆弱人群的疾病发生之间存在紧密联系。总体而言，我们的研究结果证明了定植、传播、持续存在与侵入性感染发生之间的强相关性，强调了在NICU环境中采取针对性措施预防金黄色葡萄球菌感染的重要性。

### 第二部分 AI 大师评价

本研究利用长达三年的全基因组测序精准流行病学技术，深入剖析了NICU内金黄色葡萄球菌的传播机制。研究揭示了菌株传播效率与临床侵入性感染风险之间的显著关联，并明确了共享空间、护理操作及环境蓄积库在病原体扩散中的关键作用。该发现通过关联定植、传播与发病全过程，为NICU感染防控提供了重要的分子流行病学证据，具有极高的临床指导意义。

---

## 5. β-抑制蛋白 1 是肺血管张力的关键调节因子

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41662523)
**期刊：** Proceedings of the National Academy of Sciences of the United States of America
**PMID：** 41662523
**DOI：** 10.1073/pnas.2512602123

### 第一部分 原文与翻译

**英文原标题：** Beta arrestin 1 is a key regulator of pulmonary vascular tone.

> **英文摘要：**
> Pulmonary arterial hypertension (PAH) is a serious disorder, in which increased vascular tone is one of the critical hallmarks. Since beta arrestins (bArrs) have been shown to regulate smooth muscle tone in the airways, we investigated the function of bArr1 in the pulmonary vasculature. Here, we report that bArr1 is essential for maintaining normal pulmonary arterial tone. Specifically, pulmonary arteries from bArr1-/- mice exhibited reduced NO-dependent vasorelaxation due to impaired soluble guanylyl cyclase (sGC) activity, which was restored by the heme-independent sGC activator BAY58-2667. We identified bArr1 as a binding partner of sGC and the sGC heme reductase cytochrome b5 reductase (Cyb5r3), indicating that bArr1 is vital for sensitizing sGC to NO. Finally, mice with either ubiquitous or smooth muscle-specific bArr1 deficiency developed pulmonary hypertension (PH). These findings highlight the important role of bArr1 in regulating pulmonary vascular tone and propose it as a potential therapeutic target for the treatment of PH.

> **中文摘要：**
> 肺动脉高压（PAH）是一种严重的疾病，其中血管张力增加是其关键特征之一。由于 β-抑制蛋白（bArrs）已被证明可调节气道平滑肌张力，我们研究了 bArr1 在肺血管系统中的功能。在此，我们报道 bArr1 对于维持正常的肺动脉张力至关重要。具体而言，bArr1-/- 小鼠的肺动脉由于可溶性鸟苷酸环化酶（sGC）活性受损，表现出一氧化氮（NO）依赖性血管舒张功能减弱，而这种功能可由非血红素依赖性 sGC 激活剂 BAY58-2667 恢复。我们将 bArr1 鉴定为 sGC 和 sGC 血红素还原酶细胞色素 b5 还原酶（Cyb5r3）的结合伙伴，表明 bArr1 对于使 sGC 对 NO 敏感至关重要。最后，全身性或平滑肌特异性 bArr1 缺陷的小鼠均会发展为肺高压（PH）。这些研究结果强调了 bArr1 在调节肺血管张力中的重要作用，并提出其作为治疗 PH 的潜在治疗靶点。

### 第二部分 AI 大师评价

本研究深入探讨了 β-抑制蛋白 1 (bArr1) 在肺血管张力调节中的分子机制，揭示了其作为 sGC 及 Cyb5r3 结合伙伴的关键角色。研究通过基因敲除小鼠模型，严谨地证明了 bArr1 缺失会导致一氧化氮敏感性受损并诱发肺高压。该发现不仅阐明了肺血管稳态调节的新通路，还为肺高压的治疗提供了具有潜力的分子靶点，具有显著的学术深度和临床指导意义。

---

## 6. 解码耐碳青霉烯类肺炎克雷伯菌的高毒力：基因组和表型分析揭示荚膜多糖是致病性的关键驱动因素

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41662361)
**期刊：** The Journal of infectious diseases
**PMID：** 41662361
**DOI：** 10.1093/infdis/jiag075

### 第一部分 原文与翻译

**英文原标题：** Decoding hypervirulence in carbapenem-resistant Klebsiella pneumoniae: genomic and phenotypic profiling reveals capsular polysaccharide as a key driver of pathogenicity.

> **英文摘要：**
> BACKGROUND: The global dissemination of hypervirulent carbapenem-resistant Klebsiella pneumoniae (hv-CRKP) poses escalating threats to public health. Substantial controversy persists regarding its true virulence potential, highlighting the need for reliable biomarkers to enable early diagnosis and targeted therapy. METHODS: Using a mouse subcutaneous challenge model, we characterized 59 carbapenem-resistant K. pneumoniae (CRKP) isolates, identifying 37.29% (22/59) as convergent hv-CRKP. Phenotypic and genotypic characterization, integrated with genome-wide association study (GWAS) and transcriptomic analysis, was performed, and reliable biomarkers for accurate hv-CRKP detection were identified. RESULTS: Patients infected with hv-CRKP exhibited significantly higher sepsis incidence (P = 0.028) and increased mortality. Capsule production and hypermucoviscosity robustly discriminated hv-CRKP from CRKP. GWAS identified a significant association between an SNP in the rbtT locus and the hypervirulent phenotype, whereas virulence plasmid-associated genes showed no significant association. These findings suggest chromosomally encoded factors-independent of plasmid-borne elements-contribute critically to hypervirulence. Transcriptomics revealed rcsA-mediated capsule upregulation enhances macrophage phagocytosis resistance and bacterial survival, revealing a pivotal pathogenic mechanism. Both multivariable logistic regression and LASSO regression confirmed capsule production and rcsA expression as independent and robust diagnostic biomarkers to accurately assess virulence potential in carbapenem-resistant strains. CONCLUSIONS: We conclude that clinical application of the term "hv-CRKP" requires prudent validation and emphasize the urgency of developing biomarkers to precisely identify truly hypervirulent CRKP strains.

> **中文摘要：**
> 背景：高毒力耐碳青霉烯类肺炎克雷伯菌（hv-CRKP）的全球传播对公共卫生构成了日益严重的威胁。关于其真实毒力潜力的争议仍然存在，这凸显了对可靠生物标志物的需求，以实现早期诊断和针对性治疗。方法：利用小鼠皮下感染模型，我们对59株耐碳青霉烯类肺炎克雷伯菌（CRKP）分离株进行了特征分析，鉴定出37.29%（22/59）为趋同性hv-CRKP。进行了表型和基因型鉴定，并结合全基因组关联分析（GWAS）和转录组分析，鉴定了用于准确检测hv-CRKP的可靠生物标志物。结果：感染hv-CRKP的患者脓毒症发生率显著升高（P = 0.028），且死亡率增加。荚膜产量和高黏性表型能稳健地将hv-CRKP与CRKP区分开。GWAS鉴定出rbtT位点的一个SNP与高毒力表型显著相关，而毒力质粒相关基因未显示出显著相关性。这些发现表明，独立于质粒携带元件的染色体编码因子对高毒力起到了至关重要的作用。转录组学揭示了rcsA介导的荚膜上调增强了对巨噬细胞吞噬作用的抵抗力及细菌存活率，揭示了一种关键的致病机制。多变量逻辑回归和LASSO回归均证实，荚膜产量和rcsA表达是准确评估耐碳青霉烯菌株毒力潜力的独立且稳健的诊断生物标志物。结论：我们得出结论，“hv-CRKP”这一术语的临床应用需要谨慎验证，并强调了开发生物标志物以精确识别真正高毒力CRKP菌株的紧迫性。

### 第二部分 AI 大师评价

本研究通过整合小鼠模型、GWAS及转录组学手段，深入剖析了hv-CRKP的致病机制，挑战了毒力仅由质粒驱动的传统观点。研究明确了染色体编码因子特别是rcsA介导的荚膜上调在抗吞噬中的核心作用，并提出了荚膜产量与rcsA表达量作为更精准的临床诊断标志物。该工作不仅为区分真正的高毒力菌株提供了科学依据，也为解决hv-CRKP定义的临床争议提供了重要的数据支撑。

---

## 7. 脓毒症相关急性肾损伤且需连续肾替代治疗患者入住重症监护病房与高依赖病房的预后对比：一项全国性数据库观察研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41662327)
**期刊：** Blood purification
**PMID：** 41662327
**DOI：** 10.1159/000550916

### 第一部分 原文与翻译

**英文原标题：** Intensive care unit versus high-dependency care unit for patients with sepsis-associated acute kidney injury requiring continuous kidney replacement therapy: An observational nationwide database study.

> **英文摘要：**
> BACKGROUND: Sepsis is a life-threatening condition that often leads to severe acute kidney injury (AKI). Continuous kidney replacement therapy (CKRT) can be provided to critically ill patients in resource-rich settings such as intensive care units (ICUs). However, whether different medical staffing levels exert a significant effect on the outcomes of patients with sepsis-associated AKI treated with CKRT is unknown. We aimed to compare the outcomes of patients with sepsis-associated AKI who received CKRT upon admission to an ICU versus a high-dependency unit (HDU), where the staffing intensity is lower than that in ICUs. METHODS: This retrospective cohort study used data retrieved from the Diagnosis Procedure Combination database and enrolled adult patients with sepsis admitted to an ICU or HDU between April 2018, and March 2023. We identified patients who initiated CKRT on admission and assigned them to the ICU or HDU group. We conducted matching weight analyses using propensity scores to compare the frequencies of in-hospital mortality and complications between the groups. RESULTS: Of 81,934 patients with sepsis, CKRT for severe AKI was initiated in HDUs and ICUs for 1,136 and 4,622 patients, respectively. Patients in the ICU group had higher cardiovascular Sequential Organ Failure Assessment subscores, lower body mass index, worse consciousness levels, and a greater need for mechanical ventilation compared with those in the HDU group. After adjustment, in-hospital mortality did not differ significantly between the ICU and HDU groups (-1.9 percentage points, 95% confidence interval: -5.2 to 1.4). Moreover, significant differences were not observed in complications including gastrointestinal bleeding, infections, thromboembolism, or cerebrovascular events. These findings remained consistent across the subgroup analyses. CONCLUSIONS: In this large cohort study, in-hospital mortality or other clinical outcomes did not differ significantly between patients initially treated in ICUs and HDUs. Further investigations are warranted to understand the relevant factors that guide the triage of these patients.

> **中文摘要：**
> 背景：脓毒症是一种危及生命的疾病，常导致严重的急性肾损伤（AKI）。在重症监护病房（ICU）等资源丰富的环境中，可以为危重患者提供连续肾替代治疗（CKRT）。然而，医疗配置水平的不同是否会对接受CKRT治疗的脓毒症相关AKI患者的预后产生显著影响尚不清楚。本研究旨在比较入院后入住ICU与高依赖病房（HDU，其人员配置强度低于ICU）的脓毒症相关AKI患者的预后。方法：本项回顾性队列研究利用从诊断程序组合（DPC）数据库中提取的数据，纳入了2018年4月至2023年3月期间入住ICU或HDU的成年脓毒症患者。我们识别了入院时启动CKRT的患者，并将其分为ICU组或HDU组。我们通过倾向评分匹配权重分析，比较了两组之间的住院死亡率和并发症发生率。结果：在81,934名脓毒症患者中，分别有1,136名和4,622名患者在HDU和ICU启动了针对严重AKI的CKRT。与HDU组相比，ICU组患者的心血管序贯器官衰竭（SOFA）子评分更高、身体质量指数（BMI）更低、意识水平更差，且对机械通气的需求更高。经过调整后，ICU组与HDU组的住院死亡率没有显著差异（相差-1.9个百分点，95%置信区间：-5.2至1.4）。此外，在包括胃肠道出血、感染、血栓栓塞或脑血管事件在内的并发症方面也未观察到显著差异。这些发现在各亚组分析中均保持一致。结论：在这项大型队列研究中，最初在ICU和HDU接受治疗的患者在住院死亡率或其他临床结局方面没有显著差异。需要进一步的研究来明确指导此类患者分诊的相关因素。

### 第二部分 AI 大师评价

本研究利用日本全国性大型行政数据库，深入探讨了不同强度医疗监护（ICU vs HDU）对接受CKRT治疗的脓毒症相关AKI患者预后的影响。通过严谨的倾向评分匹配权重分析，研究证实虽然入住ICU的患者基础病情通常更重，但在校正混杂因素后，两类病房的死亡率及主要并发症发生率并无统计学差异。这一结论挑战了“重症必须匹配最高强度护理”的常规思维，为医疗资源的优化分配和危重症患者的分级诊疗提供了重要的实证支持，对于缓解重症医疗资源紧张具有现实的指导意义。

---

## 8. ICU出院后的“重返常态”：JAMA纪录片聚焦重症加强护理病房后综合征 (PICS)

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41538147)
**期刊：** JAMA
**PMID：** 41538147
**DOI：** 10.1001/jama.2025.23871

### 第一部分 原文与翻译

**英文原标题：** Going Back to "Normal" After ICU Discharge: JAMA Film Documents Post-Intensive Care Syndrome (PICS).

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

本文介绍了JAMA通过纪录片形式对重症加强护理病房后综合征（PICS）进行的深度呈现。文章核心关注ICU幸存者在生理、认知和心理健康方面面临的长期挑战，探讨了患者在回归社会与日常生活过程中的障碍。这种通过叙事医学和视觉媒体结合的方式，不仅提升了临床医生对PICS多维损害的认识，也为优化术后康复管理提供了更具人文关怀的视角。

---

## 9. 重症监护后综合征。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41538138)
**期刊：** JAMA
**PMID：** 41538138
**DOI：** 10.1001/jama.2025.23666

### 第一部分 原文与翻译

**英文原标题：** Post-Intensive Care Syndrome.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

这篇在《JAMA》发表的文章聚焦于“重症监护后综合征”（PICS），反映了重症医学界对患者长期生存质量的高度关注。PICS通常涵盖患者在生理功能、认知水平及心理健康等多维度的受损表现。该文章通过对这一综合征的权威论述，旨在提升临床医生对ICU幸存者远期并发症的识别与干预能力，对完善危重症全程管理具有重要的指导意义。

---

速递结束，祝您工作愉快！